Oxaliplatin neurotoxicity - No general ion channel surface-charge effect

Journal of Negative Results in BioMedicine

Volumn 8, Issue 1, 2009, Pages

  Broomand, Amir ^a   Jerremalm, Elin ^b   Yachnin, Jeffrey ^c   Ehrsson, Hans ^b   Elinder, Fredrik ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ION CHANNEL; OXALIPLATIN; POTASSIUM CHANNEL; ANTINEOPLASTIC AGENT; CYSTEINE; PLATINUM COMPLEX; SHAKER POTASSIUM CHANNEL;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG STRUCTURE; NEUROTOXICITY; NONHUMAN; OUTCOME ASSESSMENT; PROTEIN EXPRESSION; SURFACE CHARGE; VOLTAGE CLAMP; XENOPUS; ANIMAL; CHANNEL GATING; GENETICS; METABOLISM; OOCYTE; XENOPUS LAEVIS;

ANIMALS; ANTINEOPLASTIC AGENTS; CYSTEINE; ION CHANNEL GATING; OOCYTES; ORGANOPLATINUM COMPOUNDS; SHAKER SUPERFAMILY OF POTASSIUM CHANNELS; XENOPUS LAEVIS;

EID: 60349086478     PISSN: None     EISSN: 14775751     Source Type: Journal    
DOI: 10.1186/1477-5751-8-2     Document Type: Article

References (29)

1. Oxaliplatin: a review of evolving concepts. S Mani MA Graham DB Bregman P Ivy SG Chaney, Cancer Invest 2002 20 246 263 10.1081/CNV-120001152 11901545
2. Clinical aspects and molecular basis of oxaliplatin neurotoxicity: current management and development of preventive measures. E Gamelin L Gamelin L Bossi S Quasthoff, Semin Oncol 2002 29 21 33 10.1053/sonc.2002.35525 12422305
3. Acute oxaliplatin-induced peripheral nerve hyperexcitability. RH Wilson T Lehky RR Thomas MG Quinn MK Floeter JL Grem, J Clin Oncol 2002 20 1767 1774 10.1200/JCO.2002.07.056 11919233
4. Pharmacokinetics of oxaliplatin in humans. H Ehrsson I Wallin J Yachnin, Med Oncol 2002 19 261 265 10.1385/MO:19:4:261 12512920
5. Oxaliplatin degradation in the presence of important biological sulphur-containing compounds and plasma ultrafiltrate. E Jerremalm I Wallin J Yachnin H Ehrsson, Eur J Pharm Sci 2006 28 278 283 10.1016/j.ejps.2006.03.001 16621479
6. Comparative neurotoxicity of oxaliplatin, ormaplatin, and their biotransformation products utilizing a rat dorsal root ganglia in vitro explant culture model. FR Luo SD Wyrick SG Chaney, Cancer Chemother Pharmacol 1999 44 29 38 10.1007/s002800050941 10367746
7. A possible explanation for a neurotoxic effect of the anticancer agent oxaliplatin on neuronal voltage-gated sodium channels. F Grolleau L Gamelin M Boisdron-Celle B Lapied M Pelhate E Gamelin, J Neurophysiol 2001 85 2293 2297 11353042
8. + channel kinetics on rat sensory neurons. H Adelsberger S Quasthoff J Grosskreutz A Lepier F Eckel C Lersch, Eur J Pharmacol 2000 406 25 32 10.1016/S0014- 2999(00)00667-1 11011028
9. Oxaliplatin induces hyperexcitability at motor and autonomic neuromuscular junctions through effects on voltage-gated sodium channels. RG Webster KL Brain RH Wilson JL Grem A Vincent, Br J Pharmacol 2005 146 1027 1039 16231011 10.1038/sj.bjp.0706407
10. + channels in frog peripheral myelinated axons. E Benoit S Brienza JM Dubois, Gen Physiol Biophys 2006 25 263 276 17197725
11. The effects of oxaliplatin, an anticancer drug, on potassium channels of the peripheral myelinated nerve fibres of the adult rat. A Kagiava A Tsingotjidou C Emmanouilides G Theophilidis, Neurotoxicology 2008 29 1100 1106 10.1016/j.neuro.2008.09.005 18845186
12. Structure, function, and modification of the voltage sensor in voltage-gated ion channels. SI Börjesson F Elinder, Cell Biochem Biophys 2008 52 149 174 10.1007/s12013-008-9032-5 18989792
13. Metal ion effects on ion channel gating. F Elinder P Århem, Q Rev Biophys 2003 36 373 427 10.1017/S0033583504003932 15267168
14. Lipoelectric modification of ion channel voltage gating by polyunsaturated fatty acids. SI Börjesson S Hammarstrom F Elinder, Biophys J 2008 95 2242 2253 10.1529/biophysj.108.130757 18502799
15. Novel voltage clamp to record small, fast currents from ion channels expressed in Xenopus oocytes. M Taglialatela L Toro E Stefani, Biophys J 1992 61 78 82 1311612 10.1016/S0006-3495(92)81817-9
16. + channels. HP Larsson F Elinder, Neuron 2000 27 573 583 10.1016/S0896-6273(00) 00067-2 11055439
17. + channel allows inactivation to be modulated by metal binding. G Yellen D Sodickson TY Chen ME Jurman, Biophys J 1994 66 1068 1075 8038379 10.1016/S0006-3495(94)80888- 4
18. Molecular movement of the voltage sensor in a K channel. A Broomand R Männikkö HP Larsson F Elinder, J Gen Physiol 2003 122 741 748 14610021 10.1085/jgp.200308927
19. Comparative neurotoxicity of oxaliplatin, cisplatin, and ormaplatin in a Wistar rat model. J Holmes J Stanko M Varchenko H Ding VJ Madden CR Bagnell SD Wyrick SG Chaney, Toxicol Sci 1998 46 342 351 10048138
20. Nucleolar damage correlates with neurotoxicity induced by different platinum drugs. MJ McKeage T Hsu D Screnci G Haddad BC Baguley, Br J Cancer 2001 85 1219 1225 10.1054/bjoc.2001.2024 11710838
21. Neurotoxicity of oxaliplatin and cisplatin for dorsal root ganglion neurons correlates with platinum-DNA binding. LE Ta L Espeset J Podratz AJ Windebank, Neurotoxicology 2006 27 992 1002 10.1016/j.neuro.2006.04.010 16797073
22. Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat. G Cavaletti G Tredici MG Petruccioli E Donde P Tredici P Marmiroli C Minoia A Ronchi M Bayssas GG Etienne, Eur J Cancer 2001 37 2457 2463 10.1016/S0959-8049(01)00300-8 11720843
23. Oxaliplatin degradation in the presence of chloride: identification and cytotoxicity of the monochloro monooxalato complex. E Jerremalm M Hedeland I Wallin U Bondesson H Ehrsson, Pharm Res 2004 21 891 894 10.1023/B:PHAM. 0000026444.67883.83 15180350
24. Localization of the extracellular end of the voltage sensor S4 in a potassium channel. F Elinder P Århem HP Larsson, Biophys J 2001 80 1802 1809 11259293 10.1016/S0006-3495(01)76150-4
25. 14C]calcium oxalate. DA Geller JD Ostrow EW Moore L Celic GH Nancollas, Clin Chim Acta 1989 182 255 270 10.1016/0009-8981(89)90103-4 2766550
26. Molecular characterization of Shaker, a Drosophila gene that encodes a potassium channel. A Kamb LE Iverson MA Tanouye, Cell 1987 50 405 413 10.1016/0092-8674(87)90494-6 2440582
27. Biophysical and molecular mechanisms of Shaker potassium channel inactivation. T Hoshi WN Zagotta RW Aldrich, Science 1990 250 533 538 10.1126/science.2122519 2122519
28. Multiple potassium-channel components are produced by alternative splicing at the Shaker locus in Drosophila. TL Schwarz BL Tempel DM Papazian YN Jan LY Jan, Nature 1988 331 137 142 10.1038/331137a0 2448635
29. Voltage-sensing mechanism is conserved among ion channels gated by opposite voltages. R Männikkö F Elinder HP Larsson, Nature 2002 419 837 841 10.1038/nature01038 12397358